 David Barton
Concepts (299)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Viral | 39 | 2020 | 561 | 6.710 |
Why?
| | Poliovirus | 29 | 2020 | 77 | 5.850 |
Why?
| | Virus Replication | 18 | 2020 | 392 | 2.560 |
Why?
| | Endoribonucleases | 9 | 2014 | 62 | 2.460 |
Why?
| | Viral Proteins | 11 | 2020 | 283 | 2.120 |
Why?
| | Brain Injuries, Traumatic | 5 | 2023 | 302 | 1.800 |
Why?
| | HeLa Cells | 27 | 2020 | 568 | 1.560 |
Why?
| | Picornaviridae | 3 | 2020 | 18 | 1.530 |
Why?
| | Ribavirin | 3 | 2020 | 89 | 1.330 |
Why?
| | Snake Bites | 2 | 2019 | 54 | 1.220 |
Why?
| | Recombination, Genetic | 3 | 2019 | 176 | 1.180 |
Why?
| | Viral Nonstructural Proteins | 3 | 2020 | 56 | 0.940 |
Why?
| | Hepacivirus | 6 | 2014 | 234 | 0.920 |
Why?
| | Polyadenylation | 2 | 2015 | 37 | 0.900 |
Why?
| | Air Ambulances | 1 | 2023 | 34 | 0.850 |
Why?
| | Agkistrodon | 2 | 2023 | 19 | 0.850 |
Why?
| | Emergency Medical Services | 2 | 2023 | 591 | 0.840 |
Why?
| | Nucleic Acid Conformation | 10 | 2010 | 664 | 0.820 |
Why?
| | RNA | 5 | 2020 | 821 | 0.800 |
Why?
| | Drug Resistance, Viral | 3 | 2020 | 98 | 0.770 |
Why?
| | Murine hepatitis virus | 1 | 2020 | 16 | 0.740 |
Why?
| | Protein Biosynthesis | 11 | 2008 | 389 | 0.720 |
Why?
| | Antiviral Agents | 5 | 2020 | 648 | 0.710 |
Why?
| | Hypogonadism | 2 | 2020 | 74 | 0.700 |
Why?
| | Hydrocortisone | 1 | 2021 | 272 | 0.690 |
Why?
| | Coral Snakes | 1 | 2019 | 2 | 0.660 |
Why?
| | Bupivacaine | 1 | 2018 | 32 | 0.630 |
Why?
| | Polyribosomes | 2 | 2008 | 23 | 0.620 |
Why?
| | Nerve Block | 1 | 2018 | 63 | 0.600 |
Why?
| | Cognitive Dysfunction | 1 | 2021 | 281 | 0.590 |
Why?
| | Amino Acid Substitution | 5 | 2020 | 267 | 0.580 |
Why?
| | RNA, Messenger | 6 | 2008 | 2581 | 0.570 |
Why?
| | RNA Stability | 4 | 2014 | 93 | 0.560 |
Why?
| | Viral Core Proteins | 3 | 2003 | 18 | 0.550 |
Why?
| | Base Sequence | 14 | 2012 | 2120 | 0.530 |
Why?
| | Leucine | 1 | 2016 | 111 | 0.530 |
Why?
| | Influenza A virus | 1 | 2014 | 91 | 0.470 |
Why?
| | RNA Cleavage | 1 | 2014 | 7 | 0.470 |
Why?
| | Ribonuclease, Pancreatic | 1 | 2014 | 11 | 0.470 |
Why?
| | Templates, Genetic | 3 | 2010 | 59 | 0.460 |
Why?
| | Transcription, Genetic | 7 | 2015 | 1318 | 0.450 |
Why?
| | DNA-Directed RNA Polymerases | 3 | 2020 | 52 | 0.440 |
Why?
| | Molecular Sequence Data | 11 | 2012 | 2793 | 0.430 |
Why?
| | Pain | 1 | 2018 | 713 | 0.430 |
Why?
| | Uridine | 2 | 2009 | 29 | 0.420 |
Why?
| | Host-Pathogen Interactions | 1 | 2014 | 296 | 0.400 |
Why?
| | Ribosomes | 2 | 2004 | 148 | 0.370 |
Why?
| | Conserved Sequence | 2 | 2008 | 219 | 0.370 |
Why?
| | Cysteine Endopeptidases | 2 | 2008 | 61 | 0.370 |
Why?
| | Humans | 46 | 2023 | 115901 | 0.360 |
Why?
| | Poly U | 1 | 2010 | 3 | 0.360 |
Why?
| | Open Reading Frames | 2 | 2008 | 114 | 0.350 |
Why?
| | Alcohol Drinking | 1 | 2016 | 654 | 0.350 |
Why?
| | Poly A | 1 | 2010 | 46 | 0.350 |
Why?
| | Deoxycytosine Nucleotides | 1 | 2009 | 11 | 0.350 |
Why?
| | Mutation | 8 | 2020 | 3370 | 0.330 |
Why?
| | Enterovirus | 2 | 2012 | 72 | 0.330 |
Why?
| | Wounds and Injuries | 2 | 2016 | 731 | 0.330 |
Why?
| | Enterovirus C, Human | 1 | 2008 | 1 | 0.320 |
Why?
| | Poly C | 1 | 2008 | 3 | 0.320 |
Why?
| | Eukaryotic Initiation Factor-4G | 1 | 2008 | 5 | 0.310 |
Why?
| | Uridine Monophosphate | 2 | 2008 | 15 | 0.300 |
Why?
| | Dinucleoside Phosphates | 1 | 2007 | 24 | 0.300 |
Why?
| | Base Composition | 1 | 2007 | 75 | 0.300 |
Why?
| | Mutagenesis, Site-Directed | 3 | 2016 | 345 | 0.250 |
Why?
| | Ribonucleases | 1 | 2004 | 53 | 0.240 |
Why?
| | Dendritic Spines | 2 | 2016 | 50 | 0.240 |
Why?
| | Kinetics | 5 | 2008 | 1560 | 0.230 |
Why?
| | DNA Mutational Analysis | 2 | 2016 | 378 | 0.230 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2023 | 37 | 0.210 |
Why?
| | Observational Studies as Topic | 1 | 2023 | 89 | 0.210 |
Why?
| | 5' Untranslated Regions | 4 | 2012 | 51 | 0.210 |
Why?
| | Protein Binding | 4 | 2020 | 1919 | 0.210 |
Why?
| | Animals | 12 | 2023 | 32122 | 0.210 |
Why?
| | Uridine Triphosphate | 1 | 2001 | 11 | 0.200 |
Why?
| | Cell-Free System | 5 | 2008 | 47 | 0.200 |
Why?
| | Hepatitis C | 1 | 2004 | 229 | 0.200 |
Why?
| | Protein Conformation | 3 | 2015 | 822 | 0.200 |
Why?
| | Patient Acuity | 1 | 2021 | 41 | 0.200 |
Why?
| | Male | 12 | 2023 | 56127 | 0.200 |
Why?
| | Adult | 8 | 2021 | 30817 | 0.190 |
Why?
| | Models, Molecular | 4 | 2015 | 1391 | 0.190 |
Why?
| | Genome, Viral | 4 | 2012 | 121 | 0.190 |
Why?
| | Anaphylaxis | 1 | 2023 | 148 | 0.190 |
Why?
| | RNA, Ribosomal | 2 | 2014 | 157 | 0.180 |
Why?
| | Nucleotide Motifs | 1 | 2020 | 31 | 0.180 |
Why?
| | Enterovirus B, Human | 1 | 2020 | 24 | 0.180 |
Why?
| | Picornaviridae Infections | 1 | 2020 | 29 | 0.180 |
Why?
| | Prospective Studies | 3 | 2023 | 6267 | 0.180 |
Why?
| | Sindbis Virus | 2 | 1991 | 9 | 0.180 |
Why?
| | Young Adult | 4 | 2021 | 10517 | 0.180 |
Why?
| | Carrier Proteins | 2 | 2009 | 703 | 0.180 |
Why?
| | Brain Injuries | 2 | 2016 | 451 | 0.170 |
Why?
| | Pituitary Gland | 1 | 2020 | 152 | 0.170 |
Why?
| | Ribonuclease T1 | 2 | 2009 | 5 | 0.170 |
Why?
| | Hypothalamus | 1 | 2020 | 150 | 0.170 |
Why?
| | Mutation, Missense | 2 | 2019 | 296 | 0.170 |
Why?
| | Regulatory Sequences, Nucleic Acid | 2 | 2009 | 78 | 0.160 |
Why?
| | Fascia | 1 | 2018 | 13 | 0.160 |
Why?
| | Mice | 7 | 2020 | 15073 | 0.160 |
Why?
| | Femoral Nerve | 1 | 2018 | 15 | 0.160 |
Why?
| | Mice, Inbred C57BL | 5 | 2020 | 4767 | 0.160 |
Why?
| | Guanidine | 3 | 2009 | 18 | 0.160 |
Why?
| | Apolipoprotein E4 | 1 | 2018 | 33 | 0.150 |
Why?
| | Injections | 1 | 2018 | 163 | 0.150 |
Why?
| | Anesthetics, Local | 1 | 2018 | 84 | 0.150 |
Why?
| | Amino Acid Sequence | 4 | 2008 | 2000 | 0.150 |
Why?
| | Blood-Brain Barrier | 1 | 2018 | 106 | 0.150 |
Why?
| | Inflammation Mediators | 1 | 2020 | 481 | 0.140 |
Why?
| | Plasmids | 3 | 2008 | 346 | 0.140 |
Why?
| | Peptide Initiation Factors | 1 | 1996 | 17 | 0.130 |
Why?
| | Nucleotides | 2 | 2008 | 113 | 0.130 |
Why?
| | Alcohols | 1 | 2016 | 29 | 0.130 |
Why?
| | Cohort Studies | 2 | 2023 | 4961 | 0.130 |
Why?
| | Cross-Sectional Studies | 2 | 2016 | 4449 | 0.130 |
Why?
| | Pain Management | 1 | 2018 | 291 | 0.130 |
Why?
| | Cell Line | 4 | 2014 | 2655 | 0.130 |
Why?
| | Microbial Sensitivity Tests | 1 | 2016 | 299 | 0.130 |
Why?
| | Hydrolysis | 1 | 2014 | 178 | 0.120 |
Why?
| | Injury Severity Score | 2 | 2016 | 460 | 0.120 |
Why?
| | White Matter | 1 | 2016 | 104 | 0.120 |
Why?
| | RNA Precursors | 1 | 1995 | 136 | 0.120 |
Why?
| | RNA, Small Nuclear | 1 | 2014 | 31 | 0.120 |
Why?
| | Middle Aged | 5 | 2023 | 27083 | 0.120 |
Why?
| | Gene Knockdown Techniques | 1 | 2014 | 304 | 0.110 |
Why?
| | Genetic Complementation Test | 3 | 2004 | 61 | 0.110 |
Why?
| | Macrophages | 1 | 2020 | 1281 | 0.110 |
Why?
| | Sulfur Radioisotopes | 2 | 2008 | 17 | 0.110 |
Why?
| | RNA, Double-Stranded | 2 | 2004 | 44 | 0.110 |
Why?
| | Binding Sites | 2 | 2008 | 1183 | 0.110 |
Why?
| | Adolescent | 5 | 2021 | 17956 | 0.110 |
Why?
| | Testosterone | 1 | 2016 | 336 | 0.110 |
Why?
| | Cells, Cultured | 1 | 2020 | 3916 | 0.110 |
Why?
| | Follow-Up Studies | 1 | 2021 | 4446 | 0.110 |
Why?
| | Biomarkers | 1 | 2023 | 3474 | 0.110 |
Why?
| | Protein Structure, Tertiary | 3 | 2012 | 804 | 0.100 |
Why?
| | Autoantibodies | 1 | 2020 | 1362 | 0.100 |
Why?
| | Models, Genetic | 2 | 2008 | 584 | 0.100 |
Why?
| | Patient Care Management | 1 | 2012 | 55 | 0.100 |
Why?
| | Argonaute Proteins | 1 | 2012 | 28 | 0.100 |
Why?
| | Neuropsychological Tests | 1 | 2016 | 932 | 0.100 |
Why?
| | Emergency Medical Technicians | 1 | 2012 | 42 | 0.100 |
Why?
| | Immune Evasion | 1 | 2012 | 47 | 0.100 |
Why?
| | West Nile virus | 1 | 2012 | 38 | 0.100 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2014 | 445 | 0.100 |
Why?
| | West Nile Fever | 1 | 2012 | 50 | 0.100 |
Why?
| | Semliki forest virus | 1 | 1991 | 1 | 0.100 |
Why?
| | Amyloid beta-Peptides | 1 | 2013 | 194 | 0.100 |
Why?
| | Alphavirus | 1 | 1991 | 17 | 0.100 |
Why?
| | Interferon Type I | 1 | 2012 | 129 | 0.090 |
Why?
| | Genes, Viral | 1 | 1991 | 89 | 0.090 |
Why?
| | Temperature | 3 | 2004 | 590 | 0.090 |
Why?
| | Physical Examination | 1 | 2012 | 224 | 0.090 |
Why?
| | Logistic Models | 1 | 2016 | 1865 | 0.090 |
Why?
| | RNA, Untranslated | 1 | 2012 | 114 | 0.090 |
Why?
| | Cerebral Cortex | 1 | 2013 | 390 | 0.090 |
Why?
| | Female | 4 | 2023 | 60081 | 0.090 |
Why?
| | DNA Primers | 2 | 2004 | 513 | 0.090 |
Why?
| | Exoribonucleases | 1 | 2010 | 40 | 0.080 |
Why?
| | Codon | 2 | 2007 | 86 | 0.080 |
Why?
| | Cognition | 1 | 2016 | 982 | 0.080 |
Why?
| | Mutagenesis | 2 | 2008 | 171 | 0.080 |
Why?
| | Epithelial Cells | 1 | 2014 | 965 | 0.080 |
Why?
| | Uracil | 1 | 2008 | 31 | 0.080 |
Why?
| | Genes, Dominant | 1 | 2008 | 93 | 0.080 |
Why?
| | Base Pairing | 1 | 2008 | 59 | 0.080 |
Why?
| | Cytosine | 1 | 2008 | 44 | 0.080 |
Why?
| | Prognosis | 1 | 2016 | 3342 | 0.080 |
Why?
| | Adenine Nucleotides | 1 | 2008 | 20 | 0.080 |
Why?
| | Oligoribonucleotides | 1 | 2008 | 52 | 0.080 |
Why?
| | Puromycin | 2 | 1999 | 11 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2004 | 1868 | 0.080 |
Why?
| | 3' Untranslated Regions | 1 | 2008 | 137 | 0.080 |
Why?
| | Binding, Competitive | 1 | 2008 | 200 | 0.080 |
Why?
| | Depression | 1 | 2016 | 1149 | 0.080 |
Why?
| | Protein Processing, Post-Translational | 2 | 2008 | 400 | 0.080 |
Why?
| | DNA, Complementary | 1 | 2008 | 262 | 0.070 |
Why?
| | RNA Caps | 2 | 2012 | 31 | 0.070 |
Why?
| | Aged | 4 | 2021 | 19299 | 0.070 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2008 | 172 | 0.070 |
Why?
| | Electronic Health Records | 1 | 2012 | 801 | 0.060 |
Why?
| | MicroRNAs | 1 | 2012 | 610 | 0.060 |
Why?
| | Selection, Genetic | 1 | 2007 | 244 | 0.060 |
Why?
| | Quality of Life | 1 | 2016 | 2392 | 0.060 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2005 | 80 | 0.060 |
Why?
| | Sequence Deletion | 2 | 2004 | 167 | 0.060 |
Why?
| | Phylogeny | 1 | 2008 | 802 | 0.060 |
Why?
| | Cytoplasm | 1 | 2004 | 255 | 0.060 |
Why?
| | Horses | 1 | 2023 | 97 | 0.050 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2023 | 69 | 0.050 |
Why?
| | Antivenins | 1 | 2023 | 55 | 0.050 |
Why?
| | Retrospective Studies | 4 | 2016 | 12616 | 0.050 |
Why?
| | Risk Factors | 1 | 2016 | 8714 | 0.050 |
Why?
| | Craniocerebral Trauma | 2 | 2016 | 130 | 0.050 |
Why?
| | Patients | 1 | 2023 | 164 | 0.050 |
Why?
| | Capsid | 1 | 2002 | 76 | 0.050 |
Why?
| | Interferons | 1 | 2002 | 152 | 0.050 |
Why?
| | Models, Biological | 1 | 2008 | 1647 | 0.050 |
Why?
| | Time Factors | 2 | 2004 | 6186 | 0.050 |
Why?
| | Medical Audit | 2 | 1991 | 76 | 0.050 |
Why?
| | Anisomycin | 1 | 1999 | 4 | 0.040 |
Why?
| | Enzyme Activation | 1 | 2002 | 791 | 0.040 |
Why?
| | Ricin | 1 | 1999 | 8 | 0.040 |
Why?
| | Cycloheximide | 1 | 1999 | 56 | 0.040 |
Why?
| | Peptide Chain Elongation, Translational | 1 | 1999 | 18 | 0.040 |
Why?
| | Protein Synthesis Inhibitors | 1 | 1999 | 44 | 0.040 |
Why?
| | Diphtheria Toxin | 1 | 1999 | 51 | 0.040 |
Why?
| | Protein Domains | 1 | 2020 | 209 | 0.040 |
Why?
| | Apolipoprotein E3 | 1 | 2018 | 4 | 0.040 |
Why?
| | Evolution, Molecular | 1 | 2002 | 437 | 0.040 |
Why?
| | Capillary Permeability | 1 | 2018 | 138 | 0.040 |
Why?
| | Inflammation | 2 | 2020 | 2503 | 0.040 |
Why?
| | Unconsciousness | 1 | 2016 | 18 | 0.030 |
Why?
| | Electrophoresis, Agar Gel | 1 | 1996 | 25 | 0.030 |
Why?
| | Fluoresceins | 1 | 2016 | 46 | 0.030 |
Why?
| | Subcellular Fractions | 1 | 1996 | 78 | 0.030 |
Why?
| | Maze Learning | 1 | 2016 | 87 | 0.030 |
Why?
| | Chromatography, Affinity | 1 | 1996 | 83 | 0.030 |
Why?
| | Indicators and Reagents | 1 | 1996 | 100 | 0.030 |
Why?
| | Cytidine Triphosphate | 1 | 1995 | 14 | 0.030 |
Why?
| | Guanidines | 1 | 1995 | 33 | 0.030 |
Why?
| | Golgi Apparatus | 1 | 2016 | 91 | 0.030 |
Why?
| | tau Proteins | 1 | 2016 | 72 | 0.030 |
Why?
| | Point Mutation | 1 | 1996 | 218 | 0.030 |
Why?
| | Amyloid | 1 | 2016 | 83 | 0.030 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 313 | 0.030 |
Why?
| | Immunoblotting | 1 | 1995 | 283 | 0.030 |
Why?
| | Methionine | 1 | 1995 | 145 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 1996 | 510 | 0.030 |
Why?
| | Cloning, Molecular | 1 | 1996 | 522 | 0.030 |
Why?
| | Peptides | 1 | 1999 | 862 | 0.030 |
Why?
| | Autoimmunity | 1 | 2020 | 823 | 0.030 |
Why?
| | Hospitals, Teaching | 2 | 1991 | 102 | 0.030 |
Why?
| | Dentate Gyrus | 1 | 2013 | 31 | 0.030 |
Why?
| | Coloring Agents | 1 | 2013 | 71 | 0.030 |
Why?
| | Alanine | 1 | 2013 | 103 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2020 | 2437 | 0.030 |
Why?
| | Azepines | 1 | 2013 | 73 | 0.030 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2013 | 72 | 0.030 |
Why?
| | Poliomyelitis | 1 | 1993 | 27 | 0.030 |
Why?
| | Recurrence | 1 | 2016 | 949 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2018 | 1970 | 0.030 |
Why?
| | Functional Laterality | 1 | 2013 | 202 | 0.030 |
Why?
| | District of Columbia | 1 | 2012 | 26 | 0.030 |
Why?
| | Behavior, Animal | 1 | 2016 | 471 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 1996 | 1243 | 0.030 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2012 | 17 | 0.030 |
Why?
| | Ambulances | 1 | 2012 | 50 | 0.030 |
Why?
| | Rhinovirus | 1 | 2012 | 40 | 0.030 |
Why?
| | Escherichia coli | 1 | 1996 | 730 | 0.030 |
Why?
| | Octoxynol | 1 | 1991 | 11 | 0.020 |
Why?
| | Methylation | 1 | 2012 | 206 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 794 | 0.020 |
Why?
| | Centrifugation, Density Gradient | 1 | 1991 | 41 | 0.020 |
Why?
| | Deoxycholic Acid | 1 | 1991 | 15 | 0.020 |
Why?
| | Detergents | 1 | 1991 | 41 | 0.020 |
Why?
| | Virulence | 1 | 2012 | 230 | 0.020 |
Why?
| | DEAD Box Protein 58 | 1 | 2010 | 8 | 0.020 |
Why?
| | Solubility | 1 | 1991 | 227 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2013 | 758 | 0.020 |
Why?
| | DEAD-box RNA Helicases | 1 | 2010 | 55 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2010 | 356 | 0.020 |
Why?
| | Receptors, Immunologic | 1 | 2010 | 201 | 0.020 |
Why?
| | Hippocampus | 1 | 2013 | 710 | 0.020 |
Why?
| | Brain Concussion | 1 | 2016 | 467 | 0.020 |
Why?
| | Chick Embryo | 1 | 1988 | 122 | 0.020 |
Why?
| | Receptors, Cell Surface | 1 | 2010 | 358 | 0.020 |
Why?
| | Hospital Mortality | 1 | 1991 | 784 | 0.020 |
Why?
| | Nerve Tissue Proteins | 1 | 2010 | 538 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2016 | 3583 | 0.020 |
Why?
| | Polyethylene Glycols | 1 | 1991 | 576 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2012 | 2607 | 0.020 |
Why?
| | Immunity, Innate | 1 | 2010 | 733 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2010 | 1033 | 0.010 |
Why?
| | Fibroblasts | 1 | 1988 | 838 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2010 | 2749 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 2002 | 200 | 0.010 |
Why?
| | Surface Properties | 1 | 2002 | 397 | 0.010 |
Why?
| | Emergency Service, Hospital | 1 | 1991 | 1842 | 0.010 |
Why?
| | Brefeldin A | 1 | 1997 | 15 | 0.010 |
Why?
| | Oximes | 1 | 1997 | 17 | 0.010 |
Why?
| | Cyclopentanes | 1 | 1997 | 15 | 0.010 |
Why?
| | Genetic Techniques | 1 | 1997 | 57 | 0.010 |
Why?
| | Benzimidazoles | 1 | 1997 | 137 | 0.010 |
Why?
| | Sulfonamides | 1 | 1997 | 447 | 0.010 |
Why?
| | Reading Frames | 1 | 1992 | 1 | 0.010 |
Why?
| | Helper Viruses | 1 | 1992 | 2 | 0.010 |
Why?
| | Virion | 1 | 1992 | 68 | 0.010 |
Why?
| | England | 1 | 1991 | 67 | 0.010 |
Why?
| | Peer Review | 1 | 1991 | 43 | 0.010 |
Why?
| | Trauma Severity Indices | 1 | 1991 | 111 | 0.010 |
Why?
| | Transfection | 1 | 1992 | 866 | 0.010 |
Why?
| | United Kingdom | 1 | 1991 | 232 | 0.010 |
Why?
| | Aged, 80 and over | 2 | 1991 | 6438 | 0.010 |
Why?
| | Central Nervous System | 1 | 1991 | 239 | 0.010 |
Why?
| | Infant | 2 | 1991 | 8002 | 0.000 |
Why?
| | Child, Preschool | 2 | 1991 | 9177 | 0.000 |
Why?
| | Survival Rate | 1 | 1991 | 1653 | 0.000 |
Why?
| | Child | 2 | 1991 | 18557 | 0.000 |
Why?
|
|
Barton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|